Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday

Stock Markets Jun 28, 2022 10:10
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday

Gainers

  • Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
  • Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to close at $1.01 after the company announced the commercial launch of its left-heart access products.
  • Epizyme, Inc. (NASDAQ: EPZM) jumped 55.1% to close at $1.48. Ipsen SA (OTC: IPSEY) agreed to acquire Epizyme at $1.45 per share for approximately $247 million, plus one contingent value right (CVR) per share.
  • Axsome Therapeutics, Inc. (NASDAQ: AXSM) shares surged 51.4% to settle at $37.03 after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressive disorder.
  • NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) surged 48.8% to close at $2.50 after the company reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed levels of disease-related biomarkers in people with ALS were steady, in contrast to a statistically significant decline portrayed in biomarkers when PrimeC was administered.
  • Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) climbed 42.4% to close at $1.31 on Monday.
  • InflaRx N.V. (NASDAQ: IFRX) shares climbed 38.3% to close at $0.8900 after tumbling around 34% on Friday.
  • Kiromic BioPharma, Inc. (NASDAQ: KRBP) jumped 36.1% to close at $0.4901 after dropping more than 25% on Friday. Kiromic BioPharma recently announced a strategic pipeline shift to prioritize its allogeneic, non-engineered off-the-shelf product candidate, Deltacel/KB-GDT.
  • Aspira Women's Health Inc. (NASDAQ: AWH) jumped 32.4% to close at $0.6810.
  • Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) gained 33.2% to close at $2.61.
  • Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) climbed 32.1% to close at $0.4360.
  • Femasys Inc. (NASDAQ: FEMY) gained 30.9% to settle at $2.46. Maxim (NASDAQ:MXIM) Group recently initiated coverage on Femasys with a Buy rating and announced a price target of $5.
  • Marker Therapeutics, Inc. (NASDAQ: MRKR) jumped 30.8% to close at $0.34.
  • Marker Therapeutics, last month, posted a Q1 net loss of $9.9 million.
  • Landos Biopharma, Inc. (NASDAQ: LABP) climbed 29.5% to settle at $0.79. Landos recently named Gregory Oakes as President and Chief Executive Officer.
  • Nutriband Inc. (NASDAQ: NTRB) rose 27% to close at $4.98.
  • Entrada Therapeutics, Inc. (NASDAQ: TRDA) gained 26.7% to close at $12.43.
  • Sigma Labs, Inc. (NASDAQ: SASI) rose 26.4% to close at $1.39.
  • Benitec Biopharma Inc. (NASDAQ: BNTC) gained 26.2% to close at $1.54.
  • RedHill Biopharma Ltd. (NASDAQ: RDHL) climbed 24.4% to close at $1.02. RedHill Biopharma recently announced a cost reduction plan expected to generate operational cost savings of approximately $50 million over the next 18 months.
  • Tenax Therapeutics, Inc. (NASDAQ: TENX) jumped 24.1% to close at $0.3852 after dipping more than 46% on Friday.
  • Sera Prognostics, Inc. (NASDAQ: SERA) gained 23.4% to settle at $2.16.
  • Scholar Rock Holding Corporation (NASDAQ: SRRK) surged 23.2% to close at $7.34 following the purchase of 1,497,490 shares and warrants by a company director, which was disclosed late Friday.
  • The9 Limited (NASDAQ: NCTY) gained 23.2% to close at $2.02.
  • Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) jumped 23% to close at $1.07.
  • Panbela Therapeutics, Inc. (NASDAQ: PBLA) gained 22.4% to close at $0.7490.
  • Precision BioSciences, Inc. (NASDAQ: DTIL) surged 22.1% to close at $1.77. The company announced the closing of an underwritten offering for total gross proceeds of approximately $50 million.
  • Omeros Corporation (NASDAQ: OMER) jumped 21.8% to settle at $3.18.
  • Fast Radius, Inc. (NASDAQ: FSRD) gained 21% to close at $0.5150.
  • T2 Biosystems, Inc. (NASDAQ: TTOO) rose 20.7% to close at $0.1810.
  • NextPlay Technologies, Inc. (NASDAQ: NXTP) surged 20.1% to close at $0.4378.
  • Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) rose 19.6% to close at $1.22.
  • Satsuma Pharmaceuticals, Inc. (NASDAQ: STSA) jumped 19.4% to close at $4.30.
  • Virgin Orbit Holdings, Inc. (NASDAQ: VORB) rose 19.2% to close at $3.85 after the company received approval to conduct space launch operations out of Brazil.
  • Applied Genetic Technologies Corporation (NASDAQ: AGTC) shares gained 19.1% to close at $0.7350 following a 25% drop on Friday.
  • AppTech Payments Corp. (NASDAQ: APCX) gained 18.8% to close at $0.7489.
  • Amesite Inc. (NASDAQ: AMST) jumped 18.7% to close at $0.5102.
  • Remark Holdings, Inc. (NASDAQ: MARK) climbed 18.3% to close at $0.4495.
  • NuZee, Inc. (NASDAQ: NUZE) rose 18.1% to close at $1.01.
  • Alpha Teknova, Inc. (NASDAQ: TKNO) gained 18% to close at $10.21.
  • Hillstream BioPharma, Inc. (NASDAQ: HILS) rose 17.7% to close at $0.8900 after the company announced a collaboration with Sapien Biosciences in cancer treatments to evaluate the synergy of HSB-1216 with immune checkpoint inhibitors.
  • Alaunos Therapeutics, Inc. (NASDAQ: TCRT) gained 17.3% to close at $1.10. Alaunos Therapeutics and The National Cancer Institute extended cooperative research and development agreement for development of personalized TCR-T Cell therapies to 2025.
  • Ebang International Holdings Inc. (NASDAQ: EBON) gained 17.1% to close at $0.4340. Ebang International announced the receipt of Nasdaq notification regarding minimum bid price deficiency.
  • XORTX Therapeutics Inc. (NASDAQ: XRTX) rose 17.1% to close at $1.44.
  • Aptinyx Inc. (NASDAQ: APTX) jumped 16.8% to close at $0.52.
  • Creatd, Inc. (NASDAQ: CRTD) gained 16.6% to settle at $0.8671.
  • Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) jumped 16.5% to settle at $0.70.
  • Northern Lights Acquisition Corp. (NASDAQ: NLIT) rose 16.5% to close at $9.26.
  • ProQR Therapeutics N.V. (NASDAQ: PRQR) gained 16.3% to close at $0.7905.
  • Healthcare Triangle, Inc. (NASDAQ: HCTI) jumped 16% to close at $1.16.
  • FedNat Holding Company (NASDAQ: FNHC) gained 15.5% to close at $0.3004 after dipping over 20% on Friday. FedNat, last month, announced a $15 million investment by Hale Partnership in Monarch National Insurance Company.
  • Altamira Therapeutics Ltd. (NASDAQ: CYTO) rose 11.6% to close at $0.5701.
  • Reed's, Inc. (NASDAQ: REED) rose 11.4% to close at $0.1559 after dropping more than 20% on Friday. Reed's, last month, posted a Q1 loss of $0.05 per share.
  • Agile Therapeutics, Inc. (NASDAQ: AGRX) gained 10.4% to close at $1.27 amid the Supreme Court overturning Roe V Wade.
  • Martin Midstream Partners L.P. (NASDAQ: MMLP) shares rose 9.6% to close at $4.00. Martin Midstream Partners recently filed for mixed shelf of up to $250 million.
  • Armata Pharmaceuticals, Inc. (NYSE: ARMP) rose 9% to close at $3.65.
  • Clene Inc. (NASDAQ: CLNN) rose 6.9% to close at $3.10. Clene, last month, received a $3 million loan from the Maryland Board of Public Works to support production for its lead drug candidate CNM-Au8.
Losers
  • Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) fell 35% to close at $0.67.
  • Borqs Technologies, Inc. (NASDAQ: BRQS) shares dipped 24.4% to close at $2.15 on Monday following effect of 1:16 reverse stock split.
  • Enochian Biosciences, Inc. (NASDAQ: ENOB) dropped 21.9% to close at $2.60.
  • Anghami Inc. (NASDAQ: ANGH) dropped 21.7% to close at $5.01.
  • PetVivo Holdings, Inc. (NASDAQ: PETV) declined 21.3% to close at $2.07.
  • GreenLight Biosciences Holdings (NASDAQ: GRNA) fell 21% to close at $2.15.
  • HilleVax, Inc. (NASDAQ: HLVX) dropped 20.6% to close at $11.15. HilleVax recently reported a Q1 net loss of $67.9 million.
  • View, Inc. (NASDAQ: VIEW) fell 20.1% to settle at $1.51. View recently reported first-quarter FY22 revenue growth of 74% year-on-year to $17 million.
  • PLAYSTUDIOS, Inc. (NASDAQ: MYPS) fell 18.1% to close at $4.44.
  • Benson Hill, Inc. (NASDAQ: BHIL) fell 17.5% to close at $2.73.
  • Momentus Inc. (NASDAQ: MNTS) dipped 17.1% to close at $2.04.
  • Accelerate Diagnostics, Inc. (NASDAQ: AXDX) fell 16.9% to close at $1.13.
  • Science 37 Holdings, Inc. (NASDAQ: SNCE) dipped 16.8% to close at $2.37.
  • SIGA Technologies, Inc. (NASDAQ: SIGA) fell 16.6% to settle at $10.88. SIGA Technologies recently announced approximately $13 million in procurement orders for oral TPOXX (tecovirimat).
  • Eargo, Inc. (NASDAQ: EAR) declined 16% to close at $1.05. Eargo strengthened financial position with up to $125 million strategic investment from Patient Square (NYSE:SQ) Capital.
  • Zhong Yang Financial Group Limited (NASDAQ: TOP) dropped 16% to close at $29.29.
  • Quantum-Si incorporated (NASDAQ: QSI) dipped 15.9% to settle at $2.43.
  • Revlon, Inc. (NYSE: REV) fell 15.7% to settle at $6.70.
  • GeoVax Labs, Inc. (NASDAQ: GOVX) fell 15.1% to close at $1.07.
  • Bird Global, Inc. (NYSE: BRDS) dipped 15% to settle at $0.4731. Bird received notice of non-compliance with NYSE trading share price listing rule.
  • Polestar Automotive Holding UK PLC (NASDAQ: PSNY) fell 14.5% to close at $11.11 amid post-SPAC merger volatility following the company's Friday debut as a public company.
  • BioAtla, Inc. (NASDAQ: BCAB) dipped 13.8% to close at $3.06.
  • Weber Inc. (NYSE: WEBR) dropped 13.8% to settle at $8.24.
  • Digital Ally, Inc. (NASDAQ: DGLY) fell 13.1% to close at $0.8250.
  • Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) fell 8.7% to close at $2.94.
  • Sharecare, Inc. (NASDAQ: SHCR) shares fell 8.3% to close at $1.76. Sharecare, last month, reported better-than-expected Q1 EPS and sales results, issued Q2 and FY22 guidance and reported a $50 million buyback.
  • Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) slipped 5.4% to close at $1.77. Tonix Pharmaceuticals recently reported pricing of $30 million private placement of convertible redeemable preferred stock.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
 

Related Articles

Heron Shares Jump After Equity Financing, Q2 Earnings
Heron Shares Jump After Equity Financing, Q2 Earnings By Benzinga - Aug 09, 2022

Heron Therapeutics Inc (NASDAQ: HRTX) reported Q2 sales of $27.63 million, +23.1% Y/Y, beating the consensus of $24.31 million. Oncology sales reached $25.1 million, up from $22.4...

Sysco's Q4 Earnings Exceeds Street Expectations
Sysco's Q4 Earnings Exceeds Street Expectations By Benzinga - Aug 09, 2022

Sysco Corp (NYSE: NYSE:SYY) reported fourth-quarter FY22 sales growth of 17.5% year-on-year to $19 billion, beating the consensus of $18.21 billion. The U.S. Foodservice...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email